Search research articles
Contact Us
Filters
Showing results (51-60 of 164) with videos related to
Page
of 17
Sort By:
Cell Death Discovery
|
April 14, 2025
Galectin-3: a novel biomarker of glycogen storage disease type III
Lucille Rossiaud, Quentin Miagoux, Manon Benabides, et al.
Annals of Neurology
|
June 21, 2006
Cold extends electromyography distinction between ion channel mutations causing myotonia
Emmanuel Fournier, Karine Viala, Hélène Gervais, et al.
European Journal of Medical Research
|
July 24, 2023
French recommendations for the management of glycogen storage disease type III
Camille Wicker, Aline Cano, Valérie Decostre, et al.
European Heart Journal
|
July 31, 2015
Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases
Karim Wahbi, Wulfran Bougouin, Anthony Béhin, et al.
Neuromuscular Disorders : NMD
|
July 13, 2010
Investigating glycogenosis type III patients with multi-parametric functional NMR imaging and spectroscopy
Claire Wary, Aleksandra Nadaj-Pakleza, Pascal Laforêt, et al.
Journal of Inherited Metabolic Disease
|
October 26, 2019
Incidence and predictors of total mortality in 267 adults presenting with mitochondrial diseases
Constantinos Papadopoulos, Karim Wahbi, Anthony Behin, et al.
Neuromuscular Disorders : NMD
|
December 14, 2011
High cardiovascular morbidity and mortality in myofibrillar myopathies due to DES gene mutations: a 10-year longitudinal study
Karim Wahbi, Anthony Béhin, Philippe Charron, et al.
Journal of Inherited Metabolic Disease
|
November 26, 2019
A high prevalence of arterial hypertension in patients with mitochondrial diseases
Caroline Chong-Nguyen, Caroline Stalens, Yves Goursot, et al.
Neuromuscular Disorders : NMD
|
September 3, 2019
X-linked Emery-Dreifuss muscular dystrophy manifesting with adult onset axial weakness, camptocormia, and minimal joint contractures
Marion Brisset, Rabah Ben Yaou, Robert-Yves Carlier, et al.
Neuromuscular Disorders : NMD
|
March 4, 2022
No effect of triheptanoin in patients with phosphofructokinase deficiency
Daniel Emil Raaschou-Pedersen, Karen Lindhardt Madsen, Nicoline Løkken, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 164) with videos related to
Sort By:
Page
of 17
Cell Death Discovery
|
April 14, 2025
Galectin-3: a novel biomarker of glycogen storage disease type III
Lucille Rossiaud, Quentin Miagoux, Manon Benabides, et al.
Annals of Neurology
|
June 21, 2006
Cold extends electromyography distinction between ion channel mutations causing myotonia
Emmanuel Fournier, Karine Viala, Hélène Gervais, et al.
European Journal of Medical Research
|
July 24, 2023
French recommendations for the management of glycogen storage disease type III
Camille Wicker, Aline Cano, Valérie Decostre, et al.
European Heart Journal
|
July 31, 2015
Long-term cardiac prognosis and risk stratification in 260 adults presenting with mitochondrial diseases
Karim Wahbi, Wulfran Bougouin, Anthony Béhin, et al.
Neuromuscular Disorders : NMD
|
July 13, 2010
Investigating glycogenosis type III patients with multi-parametric functional NMR imaging and spectroscopy
Claire Wary, Aleksandra Nadaj-Pakleza, Pascal Laforêt, et al.
Journal of Inherited Metabolic Disease
|
October 26, 2019
Incidence and predictors of total mortality in 267 adults presenting with mitochondrial diseases
Constantinos Papadopoulos, Karim Wahbi, Anthony Behin, et al.
Neuromuscular Disorders : NMD
|
December 14, 2011
High cardiovascular morbidity and mortality in myofibrillar myopathies due to DES gene mutations: a 10-year longitudinal study
Karim Wahbi, Anthony Béhin, Philippe Charron, et al.
Journal of Inherited Metabolic Disease
|
November 26, 2019
A high prevalence of arterial hypertension in patients with mitochondrial diseases
Caroline Chong-Nguyen, Caroline Stalens, Yves Goursot, et al.
Neuromuscular Disorders : NMD
|
September 3, 2019
X-linked Emery-Dreifuss muscular dystrophy manifesting with adult onset axial weakness, camptocormia, and minimal joint contractures
Marion Brisset, Rabah Ben Yaou, Robert-Yves Carlier, et al.
Neuromuscular Disorders : NMD
|
March 4, 2022
No effect of triheptanoin in patients with phosphofructokinase deficiency
Daniel Emil Raaschou-Pedersen, Karen Lindhardt Madsen, Nicoline Løkken, et al.
Page
of 17